The company, which was owned by McKesson Corporation from 2014 and Aurelius Group from 2022, ceased trading in November 2023 and later entered voluntary liquidation.

[1] In November 2013, the Daily Telegraph reported that "The prices of more than 20,000 drugs could have been artificially inflated, with backhanders paid to chemists who agreed to sell them".

[5] In December 2013 it was involved in a case where Quantum Pharmaceutical was fined more than £380,000 by the Office of Fair Trading over a cartel arrangement in which it carved up some of a multimillion-pound market in prescription drugs for care homes with Lloyds Pharmacy.

[9] In 2016, Lloyds made a €12 million settlement to the Irish Health Service Executive over a dispute of phased dispensing to medical card holders.

[10] In June 2019, Lloyds acquired Echo, an online prescription fulfilment business in the UK, for an undisclosed sum.

[11] In April 2022, McKesson's UK businesses – including LloydsPharmacy, the wholesaler AAH, and a travel health service – were purchased by the Aurelius Group.

[13] The online prescription service LloydsDirect was sold to rival company Pharmacy2U in October 2023 for an undisclosed sum.